Recent Review Articles

Chada KE. et al. A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines. Vaccine. 2017 May 31;35(24):3162-3170.
Abstract

Review Articles - Avian Influenza

2012 - May 2017

Bui C. et al. A Systematic Review of the Comparative Epidemiology of Avian and Human Influenza A H5N1 and H7N9 - Lessons and Unanswered Questions. Transbound Emerg Dis. 2015 Jan 29.
Abstract

Chada KE. et al. A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines. Vaccine. 2017 May 31;35(24):3162-3170.
Abstract

Clegg C.H., Rininger J.A., Baldwin S.L. Clinical vaccine development for H5N1 influenza. Expert Rev Vaccines. 2013 Jul;12(7):767-77.
Abstract

El Zowalaty M.E. Avian influenza: virology, diagnosis and surveillance. Future Microbiology September 2013, Vol. 8, No. 9, Pages 1209-1227
Abstract

Gasparini R. et al. Aflunov(®): a prepandemic influenza vaccine. Expert Rev Vaccines. 2012 Feb;11(2):145-57.
Abstract

Gilbert M. and Pfeiffer D.U. Risk factor modelling of the spatio-temporal patterns of highly pathogenic avian influenza (HPAIV) H5N1: a review. Spat Spatiotemporal Epidemiol. 2012 Sep;3(3):173-83.
Abstract

Guo Q. et al. Immunogenicity and Safety of Pandemic Influenza H5N1 Vaccines in Healthy Adults through Meta-Analysis. Cell Physiol Biochem. 2016;40(5):921-932.
Full text

Harfoot R, Webby RJ. H5 influenza, a global update. J Microbiol. 2017 Mar;55(3):196-203.
Abstract

He B. et al. Adenovirus-based vaccines against avian-origin H5N1 influenza viruses. Microbes Infect. 2015 Feb;17(2):135-41.
Full text

Horby P. et al. The role of host genetics in susceptibility to influenza: a systematic review. PLoS One. 2012;7(3):e33180. doi: 10.1371/journal.pone.0033180. Epub 2012 Mar 15.
Full text

Imai M., Kawaoka Y. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol. 2012 Apr;2(2):160-7. doi: 10.1016/j.coviro.2012.03.003. Epub 2012 Mar 24.
Abstract

Lai S. et al. Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: a systematic review of individual case data. Lancet Infect Dis. 2016 May 17. pii: S1473-3099(16)00153-5.
Abstract

Lazarus R, Lim PL. Avian influenza: recent epidemiology, travel-related risk, and management. Curr Infect Dis Rep. 2015 Jan;17(1):456.
Abstract

Li C, Bu Z, Chen H. Avian influenza vaccines against H5N1 'bird flu'. Trends Biotechnol. 2014 Jan 31. pii:
Abstract

Lin TY, Brass AL. Host genetic determinants of influenza pathogenicity. Curr Opin Virol. 2013 Oct;3(5):531-6. doi: 10.1016/j.coviro.2013.07.005. Epub 2013 Aug 8.
Abstract

Liu Q. et al. Characteristics of human infection with avian influenza viruses and development of new antiviral agents.Acta Pharmacol Sin. 2013 Oct;34(10):1257-69.
Full text

Liu S. et al. Avian influenza virus in pregnancy. Rev Med Virol. 2016 May 17.
Abstract

Mei L. et al, Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans. BioScience Trends. 2013 ;7(2):64-76. (DOI: 10.5582/bst.2013.v7.2.64)
Full text

Mertz D. et al. Populations at Risk for Severe or Complicated Avian Influenza H5N1: A Systematic Review and Meta-Analysis. PLoS One. 2014 Mar 6;9(3):e89697.
Full text

Offeddu V, Cowling BJ, Malik Peiris JS. Interventions in live poultry markets for the control of avian influenza: a systematic review. One Health. 2016 Dec;2:55-64.
Full text

Oh DY, Hurt AC. A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade. Scientifica Vol 2014 (2014)
Full text

Osterholm MT, Kelley NS. Mammalian-transmissible H5N1 influenza: facts and perspective. MBio. 2012 Feb 24;3(2):e00045-12. doi: 10.1128/mBio.00045-12. Print 2012.
Full text

Peiris JS. et al. Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia. Lancet Infect Dis. 2015 Dec 1. pii: S1473-3099(15)00502-2.
Full text 

Plosker G.L. A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®]. Drugs. 2012 Jul 30;72(11):1543-57. doi: 10.2165/11209650-000000000-00000.
Abstract

Reperant L.A., Kuiken T., Osterhaus A.D. Adaptive pathways of zoonotic influenza viruses: from exposure to establishment in humans. Vaccine. 2012 Jun 22;30(30):4419-34. doi: 10.1016/j.vaccine.2012.04.049.
Abstract

Reperant LA, Kuiken T, Osterhaus AD. Influenza viruses: from birds to humans. Hum Vaccin Immunother. 2012 Jan;8(1):7-16.
Abstract

Sakurai A., Shibasaki F. Updated values for molecular diagnosis for highly pathogenic avian influenza virus. Viruses. 2012 Aug;4(8):1235-57.

Full text http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446759/

Shao H, Perez DR. Passive immune neutralization strategies for prevention and control of influenza A infections. Immunotherapy. 2012 Feb;4(2):175-86. doi: 10.2217/imt.11.167.
Full text

Shojaei TR. et al. A review on emerging diagnostic assay for viral detection: the case of avian influenza virus. Mol Biol Rep. 2015 Jan;42(1):187-99.
Abstract

Simms L, Jeggo M. Avian Influenza from an Ecohealth Perspective. Ecohealth. 2014 Apr 24. [Epub ahead of print]
Abstract

Su S. et al. The epidemiology, evolution and recent outbreaks of avian influenza viruses in China: A Review. J Virol. 2015 Jun 10. pii: JVI.01034-15.
Abstract

To K.K.W.et al. Avian influenza A H5N1 virus: a continuous threat to humans. Emerging Microbes Infections (2012) 1, e25
Full text

To K.K. et al. Emergence in China of human disease due to avian influenza A(H10N8) - Cause for concern? J Infect. 2014 Mar;68(3):205-215.
Abstract

Toner E.S. and Adalja AA. Is H5N1 really highly lethal? Biosecur Bioterror. 2012 Jun;10(2):237-40. doi: 10.1089/bsp.2012.0224. Epub 2012 Mar 6.
Full text

Van Kerkhove M.D. Brief literature review for the WHO global influenza research agenda – highly pathogenic avian influenza H5N1 risk in humans. Influenza and other Respiratory Viruses. Published online: 27 AUG 2013
Full text

Wang Z. et al. Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity. (Australia) Front Immunol. 2016 Mar 1;7:60.
Full text

Watanabe Y. et al. The changing nature of avian influenza A virus (H5N1). Trends Microbiol. 2012 Jan;20(1):11-20. doi: 10.1016/j.tim.2011.10.003. Epub 2011 Dec 5.
Abstract

Yin J, Liu S. Zhu Y. An overview of the highly pathogenic H5N1 influenza virus. Virol Sin. 2013 Feb;28(1):3-15.

Zhang J. Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines. Viruses. 2012 Nov 1;4(11):2711-35. doi: 10.3390/v4112711.
Full text

Zheng D, Yi Y, Chen Z. Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza. Viruses. 2012 Dec 10;4(12):3589-605. doi: 10.3390/v4123589.
Full text

Zhu W.F. et al. A review of H7 subtype avian influenza virus.[Article in Chinese] Bing Du Xue Bao. 2013 May;29(3):245-9.
Abstract